Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion type Assertion NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_head.
- NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion description "[The elevation of transforming growth factor-?2 (TGF-?2) levels in eye tissue is considered as one of the major factors contributing to posterior capsule opacification (PCO) in patients undergoing cataract surgery, since TGF-?2 is known to stimulate the cell migration of residual human lens epithelial cells (HLECs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_provenance.
- NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion evidence source_evidence_literature NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_provenance.
- NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion SIO_000772 22406872 NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_provenance.
- NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion wasDerivedFrom befree-2016 NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_provenance.
- NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_assertion wasGeneratedBy ECO_0000203 NP966821.RATPqiGn4FMV1FbyhouT3g31w9p-kUNyYAKY36iX6SHag130_provenance.